Zai Lab partners with Amgen for combination cancer therapy trial
Go back to Zai Lab partners with Amgen for combination cancer therapy trial| Amgen Inc (NASDAQ: AMGN) | Delayed: 382.47 -8.8 (2.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $391.27 | 52 Week High | $176.85 | |||
| Open | $387.84 | 52 Week Low | $133.64 | |||
| Day High | $391.67 | P/E | 57.60 | |||
| Day Low | $381.51 | EPS | $6.64 | |||
| Volume | 3,431,946 | |||||
| (NASDAQ: ZLAB) | Delayed: 24.17 -0.91 (3.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.08 | 52 Week High | $ | |||
| Open | $24.01 | 52 Week Low | $ | |||
| Day High | $24.66 | P/E | N/A | |||
| Day Low | $23.64 | EPS | $ | |||
| Volume | 1,610,169 | |||||
